AZN vs QLYS · P/E 28, $288.38B cap vs P/E 28, rev $357.8M
AstraZeneca PLC (AZN) versus Qualys Inc (QLYS) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Qualys Inc (QLYS) is a software - infrastructure company listed on US.
AZN does not have a complete income-statement cache yet.
Latest reported QLYS revenue for 2026-06-30 was $357.8M. Net income was $103.0M. QLYS currently screens at market cap $5.14B and trailing P/E 27.7.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. QLYS currently screens at market cap $5.14B and trailing P/E 27.7.
Not investment advice. Open the AZN and QLYS stock pages for the full models.
Not investment advice.